These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24395723)

  • 21. Relationship between red cell distribution width and contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention.
    Akkoyun DÇ; Akyüz A; Kurt Ö; Bilir B; Alpsoy Ş; Güler N
    Turk Kardiyol Dern Ars; 2015 Oct; 43(7):613-20. PubMed ID: 26536986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contrast-induced nephropathy in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Elbasan Z; Şahin DY; Gür M; Kuloğlu O; Kivrak A; Içen YK; Türkoglu C; Yildirim A; Özdogru I; Çayli M
    Angiology; 2014 Jan; 65(1):37-42. PubMed ID: 23109331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of risks and clinical predictors of contrast-induced nephropathy in patients undergoing emergency versus nonemergency percutaneous coronary interventions.
    Chong E; Poh KK; Liang S; Soon CY; Tan HC
    J Interv Cardiol; 2010 Oct; 23(5):451-9. PubMed ID: 20796168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Red cell distribution width predicts contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
    Kurtul A; Yarlioglues M; Murat SN; Demircelik MB; Acikgoz SK; Ergun G; Duran M; Cetin M; Ornek E
    Angiology; 2015 May; 66(5):433-40. PubMed ID: 24834929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast-induced acute kidney injury in patients with non-ST-segment elevation myocardial infarction undergoing early versus delayed invasive strategy.
    Kocas B; Abaci O; Cetinkal G; Arslan S; Dalgic Y; Kocas C; Yildiz A; Ersanli M
    Int J Cardiol; 2016 Jan; 203():638-9. PubMed ID: 26580347
    [No Abstract]   [Full Text] [Related]  

  • 26. Acute Kidney Injury After Primary Angioplasty: Is Contrast-Induced Nephropathy the Culprit?
    Caspi O; Habib M; Cohen Y; Kerner A; Roguin A; Abergel E; Boulos M; Kapeliovich MR; Beyar R; Nikolsky E; Aronson D
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28647690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Water for contrast-induced nephropathy? A thirst for knowledge.
    Pate GE; Webb JG
    J Invasive Cardiol; 2003 Dec; 15(12):703-5. PubMed ID: 14660822
    [No Abstract]   [Full Text] [Related]  

  • 28. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.
    Nakahashi H; Kosuge M; Sakamaki K; Kiyokuni M; Ebina T; Hibi K; Tsukahara K; Iwahashi N; Kuji S; Oba MS; Umemura S; Kimura K
    Heart Vessels; 2017 Jan; 32(1):22-29. PubMed ID: 27106917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation of homocysteinemia to contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.
    Kim SJ; Choi D; Ko YG; Kim JS; Han SH; Kim BK; Kang SW; Hong MK; Jang Y; Choi KH; Yoo TH
    Am J Cardiol; 2011 Oct; 108(8):1086-91. PubMed ID: 21791335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty.
    Ivanes F; Isorni MA; Halimi JM; Fauchier L; Saint Etienne C; Babuty D; Angoulvant D; Brunet-Bernard A
    Arch Cardiovasc Dis; 2014; 107(8-9):424-32. PubMed ID: 25082735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dosing of iodinated contrast volume: a new simple algorithm to stratify the risk of contrast-induced nephropathy in patients with acute coronary syndrome.
    Raposeiras-Roubín S; Abu-Assi E; Ocaranza-Sánchez R; Alvarez-Álvarez B; Cambeiro-González C; Fandiño-Vaquero R; García-Castelo A; García-Acuña JM; González-Juanatey JR
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):888-97. PubMed ID: 23362013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minimizing contrast dose according to estimated glomerular filtration rate.
    Yasuda Y; Suzuki S; Ishii H
    Circ J; 2014; 78(1):59-60. PubMed ID: 24334559
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial.
    Thayssen P; Lassen JF; Jensen SE; Hansen KN; Hansen HS; Christiansen EH; Junker A; Ravkilde J; Thuesen L; Veien KT; Jensen LO
    Circ Cardiovasc Interv; 2014 Apr; 7(2):216-24. PubMed ID: 24714489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous coronary intervention without onsite cardiac surgery backup.
    Dubey L; Sharma SK; Bhattacharya R; Guruprasad S; Subramanyam G
    JNMA J Nepal Med Assoc; 2013; 52(189):267-71. PubMed ID: 23591308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nephrotoxicity from contrast media: attenuation with theophylline.
    Morcos SK; Brown PW
    Radiology; 1995 Nov; 197(2):546-7; dicussion 248. PubMed ID: 7480713
    [No Abstract]   [Full Text] [Related]  

  • 36. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
    Bolognese L; Falsini G; Schwenke C; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
    Am J Cardiol; 2012 Jan; 109(1):67-74. PubMed ID: 21943940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sodium bicarbonate plus N-acetylcysteine to prevent contrast-induced nephropathy in primary and rescue percutaneous coronary interventions: the BINARIO (BIcarbonato e N-Acetil-cisteina nell'infaRto mIocardico acutO) study.
    Leone AM; De Caterina AR; Sciahbasi A; Aurelio A; Basile E; Porto I; Trani C; Burzotta F; Niccoli G; Mongiardo R; Mazzari MA; Buffon A; Panocchia N; Romagnoli E; Lioy E; Rebuzzi AG; Crea F
    EuroIntervention; 2012 Nov; 8(7):839-47. PubMed ID: 23171803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired renal function in acute myocardial infarction.
    Lekston A; Kurek A; Tynior B
    Cardiol J; 2009; 16(5):400-6. PubMed ID: 19753517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating tumour necrosis factor receptors 1 and 2 predict contrast-induced nephropathy and progressive renal dysfunction: a prospective cohort study.
    An JN; Yoo KD; Hwang JH; Kim HL; Kim SH; Yang SH; Kim JH; Kim DK; Oh YK; Kim YS; Lim CS; Lee JP
    Nephrology (Carlton); 2015 Aug; 20(8):552-9. PubMed ID: 25783484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation of uric acid and contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention in the ED.
    Saritemur M; Turkeli M; Kalkan K; Tanboga İH; Aksakal E
    Am J Emerg Med; 2014 Feb; 32(2):119-23. PubMed ID: 24238488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.